BACKGROUND: Pulmonary fibrosis occurs when myofibroblasts and the extracellular matrix (ECM) excessively accumulate in the lung interstitium. Detailed studies elucidating the role of cleavage and polyadenylation-specific factor 6 (CPSF6) during fibroblast-myofibroblast transition (FMT) remain limited. METHODS: A silica-induced mouse pulmonary fibrosis model and a transforming growth factor-β1 (TGF-β1) induced fibroblast activation model were performed to investigate the role and mechanism of CPSF6. The expression of CPSF6 and profibrotic markers was determined by quantitative real-time polymerase chain reaction (qRT-PCR) analysis, Western blotting, and immunofluorescence assays. Dual-luciferase reporter gene assays and RNA immunoprecipitation (RIP) assays were performed to investigate the association between RUNX1 3' untraslated region (3â²UTR) and miR-30a-5p. RESULTS: CPSF6 was downregulated in silica-induced murine fibrotic lung tissues and primary fibroblasts. Silencing CPSF6 via adeno-associated virus (AAV) in vivo exacerbated pulmonary fibrosis, while ectopic CPSF6 expression mitigated the condition. TGF-β1 effectively decreased CPSF6 expression in fibroblasts (MRC-5 and mouse primary lung fibroblast). CPSF6 overexpression blocked the profibrotic effect of TGF-β1, while inhibition of CPSF6 was found to trigger FMT. Notably, Runt-related transcription factor 1 (RUNX1), a crucial transcription factor implicated in fibrosis, was identified as a downstream effector of CPSF6. Mechanistically, CPSF6 loss favored the utilization of the proximal poly (A) site in the 3'UTR of RUNX1, leading to the production of a short 3'UTR RUNX1 transcript and more protein by avoiding being targeted for degradation by miR-30a-5p. CONCLUSIONS: CPSF6 is implicated in the pathogenesis of fibrosis through its function in fibroblast activation, thereby enhancing the mechanistic understanding of fibrotic progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12931-026-03507-7.
CPSF6-mediated alternative polyadenylation of RUNX1 to regulate silica-induced pulmonary fibrosis progression.
阅读:1
作者:Yang Huanyu, Zhang Li, Han Mengjia, Wu Qiongxiao, Zhang Chengye, Xu Qi
| 期刊: | Respiratory Research | 影响因子: | 5.000 |
| 时间: | 2026 | 起止号: | 2026 Jan 16; 27(1):58 |
| doi: | 10.1186/s12931-026-03507-7 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
